Article

Immunotherapy Combined with Chemotherapy versus Chemotherapy Alone in Advanced Pancreatic Ductal Adenocarcinoma: a Real-world Retrospective Cohort Study

2026-08-06

Abstract excerpt

<title>Abstract</title> <p> Purpose Chemotherapy remains the standard first-line therapy for advanced pancreatic ductal adenocarcinoma (PDAC), while the benefit of adding immunotherapy remains controversial. In this study, we evaluated the efficacy and safety of first-line immuno-chemotherapy in advanced PDAC. Methods This retrospective study included 203 patients with advanced PDAC treated at the First Affili...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: c13c9e86-27a1-5f6a-a3c5-18f387fa4545
DOI: 10.21203/rs.3.rs-10486473/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Immunotherapy Combined with Chemotherapy versus Chemotherapy Alone in Advanced Pancreatic Ductal Adenocarcinoma: a Real-world Retrospective Cohort StudyDOI 10.21203/rs.3.rs-10486473/v1Read

Toripalimab combined with albumin-paclitaxel plus gemcitabine as first-line treatment for locally advanced or metastatic pancreatic ductal adenocarcinoma: an open-label, phase Ib/II study and investigation of potential biomarkersSemantic proximity Read

PD-1 Inhibitor Plus Chemotherapy Versus Chemotherapy for First-Line Treatment in Advanced Esophageal Cancer: A Systematic Review and Meta-Analysis.Semantic proximity Read

PD-1 blockade plus capecitabine as curative-intent treatment for tumor mutational burden-high multi-metastatic pancreatic ductal adenocarcinoma: A case reportSemantic proximity Read

Exploring prognostic survival factors in patients with advanced pancreatic cancer receiving PD-1 inhibitorsSemantic proximity Read

Systematic review and meta-analysis on targeted therapy in advanced pancreatic cancer.Semantic proximity Read

Optimizing Chemotherapy of Pancreatic Acinar Cell Carcinoma: Our Experiences and Pooled Analysis of LiteraturesSemantic proximity Read

Current and future therapies for advanced pancreatic cancer.Semantic proximity Read

Advances in the Treatment of Pancreatic CancerSemantic proximity Read

New therapeutic targets in pancreatic cancer.Semantic proximity Read

Dendritic Cell/Cytokine-Induced Killer Cell Immunotherapy Combined with S-1 in Patients with Advanced Pancreatic Cancer: A Prospective Study.Semantic proximity Read

A step towards personalizing next line therapy for resected pancreatic and related cancer patients: A single institution's experience.Semantic proximity Read

Advancing Immunotherapy in Pancreatic Cancer: A Brief Review of Emerging Adoptive Cell TherapiesSemantic proximity Read